LEUKOCYTE CHEMOATTRACTANT PEPTIDES FROM THE SERPIN HEPARIN COFACTOR-II

被引:0
|
作者
CHURCH, FC
PRATT, CW
HOFFMAN, M
机构
[1] UNIV N CAROLINA, DEPT PATHOL, CHAPEL HILL, NC 27599 USA
[2] UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC 27599 USA
[3] UNIV N CAROLINA, CTR THROMBOSIS & HEMOSTASIS, CHAPEL HILL, NC 27599 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heparin cofactor II (HC) is a plasma serine proteinase inhibitor (serpin) that inhibits the coagulant proteinase alpha-thrombin. We have recently demonstrated that proteolysis of HC by catalytic amounts of polymorphonuclear leukocyte proteinases (elastase or cathepsin G) generates leukocyte chemotaxins (Hoffman, M., Pratt, C. W., Brown, R. L., and Church, F. C. (1989) Blood 73, 1682-1685). One of four peptides produced when HC is degraded by neutrophil elastase has chemotactic activity for both monocytes and neutrophils with maximal migration comparable to formyl-Met-Leu-Phe, the "gold standard" bacterially derived chemotaxin. The amino-terminal sequence of this HC peptide is Asp-Phe-His-Lys-Glu-Asn-Thr-Val-... and the peptide corresponds to Asp-39 to Ile-66 of HC. A variety of synthetic peptides derived from this sequence were evaluated for leukocyte migration activity, and a dodecapeptide from Asp-49 to Tyr-60 (Asp-Trp-Ile-Pro-Glu-Gly-Glu-Glu-Asp-Asp-Asp-Tyr) was identified as the active site for leukocyte chemotactic action. The 12-mer synthetic peptide possesses significant neutrophil chemotactic action at 1 nM (60% of the maximal activity of formyl-Met-Leu-Phe), while a peptide with the reverse sequence has essentially no chemotactic activity. Cross-desensitization experiments also show that pretreatment of neutrophils with a 19-mer peptide (Asn-48 to Ile-66) greatly reduces subsequent chemotaxis to HC-neutrophil elastase proteolysis reaction products. When injected intraperitoneally in mice, the HC-neutrophil elastase digest elicits neutrophil migration. Our results demonstrate that not only does HC function as a thrombin inhibitor, but that limited proteolysis of HC near the amino terminus yields biologically active peptide(s) which might participate in inflammation and in wound healing and tissue repair processes.
引用
收藏
页码:704 / 709
页数:6
相关论文
共 50 条
  • [21] ROLE OF LYSINE 173 IN HEPARIN BINDING TO HEPARIN COFACTOR-II
    WHINNA, HC
    BLINDER, MA
    SZEWCZYK, M
    TOLLEFSEN, DM
    CHURCH, FC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (13) : 8129 - 8135
  • [22] INVIVO AND INVITRO CONSUMPTION OF DERMATAN SULFATE COFACTOR (HEPARIN COFACTOR-II)
    ABILDGAARD, U
    ANDERSSON, TR
    LARSEN, ML
    HANDELAND, GF
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 203 - 203
  • [23] HEPARIN COFACTOR-II IN ADULTS AND INFANTS WITH THROMBOSIS AND DIC
    CHUANSUMRIT, A
    MANCOJOHNSON, MJ
    HATHAWAY, WE
    AMERICAN JOURNAL OF HEMATOLOGY, 1989, 31 (02) : 109 - 113
  • [24] HEPARIN COFACTOR-II - PURIFICATION AND ANTIBODY-PRODUCTION
    TRAN, TH
    LAMMLE, B
    ZBINDEN, B
    DUCKERT, F
    THROMBOSIS AND HAEMOSTASIS, 1986, 55 (01) : 19 - 23
  • [25] LABORATORY DIAGNOSIS OF ANTITHROMBIN AND HEPARIN COFACTOR-II DEFICIENCY
    TOLLEFSEN, DM
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1990, 16 (02): : 162 - 168
  • [26] HEPARIN COFACTOR-II DEFICIENCY - A RISK FACTOR FOR THROMBOPHILIA
    TOULON, PA
    VITOUX, JF
    FIESSINGER, JN
    SULTAN, Y
    AIACH, M
    ARTERIOSCLEROSIS, 1988, 8 (05): : A687 - A688
  • [27] DERMATAN SULFATE AND HEPARIN CAN BE FRACTIONATED BY AFFINITY FOR HEPARIN COFACTOR-II
    GRIFFITH, MJ
    MARBET, GA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 112 (02) : 663 - 670
  • [28] HEPARIN COFACTOR-II IN WASHED HUMAN-PLATELETS
    TOULON, P
    AMIRAL, J
    AIACH, M
    SULTAN, Y
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 192 - 192
  • [29] ROLE OF THROMBIN EXOSITES IN INHIBITION BY HEPARIN COFACTOR-II
    ROGERS, SJ
    PRATT, CW
    WHINNA, HC
    CHURCH, FC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (06) : 3613 - 3617
  • [30] HEPARIN COFACTOR-II IN ADULT GLOMERULOPATHY AND NEPHROTIC SYNDROME
    PECH, MA
    ROSTOKER, G
    SORIA, C
    LANG, P
    WEIL, B
    CAEN, J
    LAGRUE, G
    AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (01) : 74 - 75